8-8:45am (Early-Stage NSCLC) Dr. Dowell

9-9:45am (Neoadjuvant NSCLC case discussion) Dr. Dowell and Dr. Von Itzstein

10-10:45am (Virtual) (Stage IV NSCLC without Molec Target) Dr. Rashdan

Session date: 
10/17/2024 - 8:00am to 10:45am CDT
Location: 
In-person & Virtual Teams
United States
See map: Google Maps
Add to calendar: 

Please login or create an account to take this course.
Faculty List: 
Committee member(s)

Monika Kumar, MD

has no relevant financial relationships to disclose at this time.
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

Jonathan Dowell

has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with takeda;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with catalyst;.
has a financial relationship (Professional Services) with astra zeneca;.

Mitch von Itzstein, MD

has no relevant financial relationships to disclose at this time.